National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

ofatumumab (oh-FAT-oo-moo-mab)

 A monoclonal antibody being studied in the treatment of certain types of B-cell cancers including chronic lymphocytic leukemia (CLL) and follicular non-Hodgkin lymphoma. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Ofatumumab binds to CD20, a protein on the surface of normal B cells and most B-cell tumors. Also called HuMax-CD20.



Previous Definitions:octreotide scan, ocular melanoma, odds ratio, odor, odorant
Next Definitions:off-label, Office for Human Research Protections, ofloxacin, OGF, OGX-011

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov